Clinical Trial Update: A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the efficacy of a budesonide/glycopyrronium/formoterol fumarate inhalation product for cardiopulmonary outcomes in ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: COPD (Chronic Obstructive Pulmonary Disease) | Phase 3 | Status: RECRUITING